Table 1.
Study | No. | Institution | Cancer diagnosis | Enrollment methodology | AI source | AI methodology | Algorithm runtime | Conclusion |
---|---|---|---|---|---|---|---|---|
Alexander et al. (14) | 102 | Peter MacCallum Cancer Center, Melbourne, Australia | Lung | Clinical data extracted from study database and medical records to match patients to 10 phase I-III cancer clinical trials on clinicaltrials.gov at local cancer center | Watson for Clinical Trial Matching (WCTM), developed by IBM | Trial data intake was optimized with 3 rounds of trial ingestion by NLP before matching patients to clinical trials based on primary cancer staging, metastatic disease, performance status, mutations, prior cancer therapy, lung surgery type, cancer histology, demographics, echocardiography, pathology, past medical history, medications, comorbidities | 15.5 s | The AI-based clinical trial matching system allows efficient and reliable screening of cancer patients for clinical trials |
Beck et al. (15) | 239 | Highlands Oncology Group, Arkansas, USA | Breast | Structured and unstructured patient data were included to assess clinical trials eligibility to 4 breast cancer trials listed on clinicaltrials.gov at local cancer center | Watson for Clinical Trial Matching (WCTM), developed by IBM | Trial data intake was optimized with 3 rounds of trial intake before used to match patients to clinical trials based on structured patient data (laboratory tests, sex, cancer diagnosis, age) and unstructured data sources (most recent medical progress note) | 24 min, which is 78% reduction compared with manual screening | Clinical trial matching system displayed a promising performance in screening patients with breast cancer for trial eligibility |
Calaprice-Whitty et al. (16) | 48 124 | Comprehensive Blood and Cancer Center, Bakersfield, CA, USA | Breast, lung | Structured and unstructured medical records evaluated to identify eligible patients retrospectively in 3 completed trials at local cancer center | Mendel.ai, developed by Mendel | Text recognition system to extract text from scanned medical documents, clinical language understanding, and entailment system to read output of text recognition system and its meanings, knowledge-based ontology and wisdom system to synthesize data to data dictionary |
|
Augmentation of human resources with artificial intelligence could yield sizable improvements over standard practices in several aspects of the patient prescreening process, as well as in approaches to feasibility, site selection, and trial selection |
Cesario et al. (17) | 96 | Comprehensive Cancer Center, Roma, Italy | Breast, lung | Digital research assistant via progressive web app identifies patients eligible for a clinical trial of all those conducted at the cancer center | Digital Research Assistant, developed in-house | AI-based models using age, immunophenotype, genetics, histology, BMI, stage of therapy | NR | Might represent a valid research tool supporting clinicians and scientists to optimize the enrollment of patients in clinical trials |
Cuggia et al. (18) | 285 | Centre Eugene Marquis, Rennes, France | Prostate | Automatic selection of clinical trials eligibility criteria (national research project) to retrospectively identify patients discussed in multidisciplinary meetings for clinical trial eligibility, for eligibility of 4 clinical trials conducted at cancer center | Computerized recruitment support system, developed as a French national research project | Computerized recruitment support system based on semantic web approach | NR | System was scalable to other clinical domains |
Delorme et al. (19) | 264 | Gustave Roussy Cancer Campus, Villejuif, France | All | Free text consultation reports evaluated to identify eligible patients retrospectively included in phase I or II oncology trials | Model developed in-house | Natural language preprocessing pipeline to turn free text into numerical features for random forest model | NR | Machine learning with semantic conservation is a promising tool to assist physicians in selecting patients prone to achieve successful screening and dose-limiting toxicity period completion in early phase oncology clinical trials |
Haddad et al. (20) | 318 | Mayo Clinic, Rochester, MN, USA | Breast | Structured and unstructured medical records evaluated to identify eligible patients for 4 breast cancer trials listed on clinicaltrials.gov at local cancer center | Watson for Clinical Trial Matching (WCTM), developed by IBM | NLP to identify cancer stage, cancer subtype, genetic markers, prior cancer therapy, surgical status, pathology, therapy-related characteristics | NR | Accurately exclude ineligible patients and offer potential to increase screening efficiency and accuracy |
Meystre et al. (21) | 229 | Hollings Cancer Center, Charleston, SC, USA | Breast | Clinical notes assessed to assess eligibility for 3 breast cancer clinical trials at local cancer center | Model developed in-house | Named entity recognition task based on sequential token-based labeling using a support vector machine retrieved clinical notes, extracted eligibility criteria | NR | Can be used to extract eligibility criteria from HER clinical notes and automatically discover patients possibly eligible for a clinical trial with good accuracy, which could be leveraged to reduce the workload of humans screening patients for trials |
Ni et al. (22) | NR | Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA | All | Demographics and notes processed to evaluate eligibility to all 70 clinical trials at local cancer center | Model developed in-house | NLP and information extraction of demographics, diagnoses, clinical notes | 1 min, which saves 346 min of manpower | Could dramatically increase trial screening efficiency of oncologists and enable participation of small practices, which are often left out from trial enrollment |
Zeng et al. (23) | NR | MD Anderson Cancer Center, Houston, TX, USA | All | Genetic textual document repositories and matching documents assessed to evaluate eligibility for 153 preprocessed potential targeted therapy clinical trials from clinicaltrials.gov and MD Anderson clinical trial database | Model developed in-house | Genetic textual document repository to identify 1 of 543 genes whose molecular abnormality can be detected on sequencing panels | NR | NLP tool was generalizable; tool may partially automate process of information gathering |
AI = artificial intelligence; BMI = body mass index; NLP = natural language processing; NR = not reported.